BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jun 14, 2004
 |  BioCentury  |  Finance

ASCO hangover

ASCO hangover

Company 6/10 cls Wk chg % chg Mcap chg 6/10 Mcap Select ASCO data Partner
Genentech (DNA) $51.75 -$7.86 -13% -$8,332 $54,855 Tarceva data (see OSI below) served as the big driver on the week. Other key ASCO events were positive Phase II data for Avastin plus gemcitabine in metastatic pancreatic cancer....

Read the full 344 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >